Role for Lipids in the Maintenance of Chemokine and T-Cell Receptor Signaling

脂质在维持趋化因子和 T 细胞受体信号传导中的作用

基本信息

  • 批准号:
    7592059
  • 负责人:
  • 金额:
    $ 10.03万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

Lipid rafts play an important role in signal integration and cellular activation of a number of cytokine and growth factor receptors. Flotillin proteins have recently been shown to be recruited to lipid raft microdomains upon cellular activation and have been implicated in neural cell regeneration, receptor signaling and lymphocyte activation. However, little is known about the relevance of the flotillin proteins in T cell responses to chemoattractant stimulation. To this end, cytoplasmic and lipid raft fractions from human T cells were analyzed for flotillin protein redistribution prior to and after CXCL12 stimulation. Flotillin-1 but not flotillin-2 redistributes to lipid rafts upon CXCR4 ligation. Moreover, in CXCL12-treated T cells, flotillin-1 also associates with several raft proteins including LAT, Lck, CD48 and CD11a. In addition, an increase in CXCR4 association with flotillin-1 in lipid rafts was observed after chemokine treatment. RNAi technology was also utilized to inhibit the expression of flotillin-1 resulting in an inhibition of CXCL12-mediated signaling, function and CXCR4 recruitment into lipid rafts. Together, these data suggest that the association of flotillin-1 with lipid raft during chemokine exposure may play an important role in chemokine receptor recruitment to and signaling in lipid rafts and possibly in leading edge formation. Overall, we believe that a greater understanding of the various signaling and cell surface proteins associated with lipid rafts may provide insight into age-related alterations in cell signaling and trafficking.
脂筏在信号整合和细胞内多种细胞因子和生长因子受体的活化中起重要作用。Flotillin蛋白最近已被证明在细胞活化后被募集到脂筏微结构域,并且已经涉及神经细胞再生、受体信号传导和淋巴细胞活化。 然而,很少有人知道的相关性的flotillin蛋白的T细胞反应的化学引诱物刺激。 为此,在CXCL 12刺激之前和之后,分析来自人T细胞的细胞质和脂筏级分的flotillin蛋白质再分布。在CXCR 4连接后,Flotillin-1而不是Flotillin-2重新分布到脂筏。 此外,在CXCL 12处理的T细胞中,flotillin-1还与包括LAT、Lck、CD 48和CD 11 a在内的几种筏蛋白结合。 此外,在趋化因子处理后,观察到CXCR 4与脂筏中的flotillin-1的结合增加。RNAi技术也被用于抑制flotillin-1的表达,从而抑制CXCL 12介导的信号传导、功能和CXCR 4向脂筏中的募集。总之,这些数据表明,在趋化因子暴露过程中,flotillin-1与脂筏的关联可能在趋化因子受体募集和脂筏信号传导中以及可能在前缘形成中发挥重要作用。 总体而言,我们认为,更好地了解与脂筏相关的各种信号和细胞表面蛋白质,可能会提供洞察细胞信号和贩运的年龄相关的变化。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DENNIS D. TAUB其他文献

DENNIS D. TAUB的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DENNIS D. TAUB', 18)}}的其他基金

Phenotypic And Functional Changes In Circulating T Cells
循环 T 细胞的表型和功能变化
  • 批准号:
    6530497
  • 财政年份:
  • 资助金额:
    $ 10.03万
  • 项目类别:
Thymic Involution And Age-associated Changes In T Cells
T 细胞的胸腺退化和年龄相关变化
  • 批准号:
    6530518
  • 财政年份:
  • 资助金额:
    $ 10.03万
  • 项目类别:
Homocysteine Stimulates Human T Cell Effector Cell
同型半胱氨酸刺激人类 T 细胞效应细胞
  • 批准号:
    6530501
  • 财政年份:
  • 资助金额:
    $ 10.03万
  • 项目类别:
Immunoregulatory and Adjuvant effects of Hormones on the
激素对免疫调节和辅助作用
  • 批准号:
    6674114
  • 财政年份:
  • 资助金额:
    $ 10.03万
  • 项目类别:
Mechanisms that Regulate Thymic Involution and Age-Assoc
调节胸腺复旧和年龄相关的机制
  • 批准号:
    6674124
  • 财政年份:
  • 资助金额:
    $ 10.03万
  • 项目类别:
Gene Expression Induced by HIV-1 and Chemokine Receptor
HIV-1 和趋化因子受体诱导的基因表达
  • 批准号:
    6969410
  • 财政年份:
  • 资助金额:
    $ 10.03万
  • 项目类别:
Mechanisms that Regulate Thymic Involution and Age-Assoc
调节胸腺复旧和年龄相关的机制
  • 批准号:
    6969413
  • 财政年份:
  • 资助金额:
    $ 10.03万
  • 项目类别:
Homocysteine Stimulates T Cell Activation, Apoptosis and Thymic Involution
同型半胱氨酸刺激 T 细胞激活、凋亡和胸腺复旧
  • 批准号:
    8552469
  • 财政年份:
  • 资助金额:
    $ 10.03万
  • 项目类别:
Characterization of Immune Alterations Associated with the Aging Process
与衰老过程相关的免疫改变的特征
  • 批准号:
    8552317
  • 财政年份:
  • 资助金额:
    $ 10.03万
  • 项目类别:
HIV Pathogenesis: Differential Effects on Lymphocyte Sub
HIV 发病机制:对淋巴细胞亚群的不同影响
  • 批准号:
    7324968
  • 财政年份:
  • 资助金额:
    $ 10.03万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 10.03万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 10.03万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 10.03万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.03万
  • 项目类别:
    Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 10.03万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 10.03万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 10.03万
  • 项目类别:
    Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
  • 批准号:
    10699504
  • 财政年份:
    2023
  • 资助金额:
    $ 10.03万
  • 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
  • 批准号:
    10491642
  • 财政年份:
    2023
  • 资助金额:
    $ 10.03万
  • 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
  • 批准号:
    10782567
  • 财政年份:
    2023
  • 资助金额:
    $ 10.03万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了